SWOG clinical trial number
SWOG-8822
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL-2) in Patients with Malignant Lymphoma
Closed
Phase
Accrual
6%
Abbreviated Title
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL-2) in Patients with Malignant Lymphoma
Activated
05/01/1989
Closed
06/15/1991